BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26631483)

  • 1. L-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway.
    Lommel MJ; Trairatphisan P; Gäbler K; Laurini C; Muller A; Kaoma T; Vallar L; Sauter T; Schaffner-Reckinger E
    FASEB J; 2016 Mar; 30(3):1218-33. PubMed ID: 26631483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness.
    Machado RAC; Stojevski D; De Landtsheer S; Lucarelli P; Baron A; Sauter T; Schaffner-Reckinger E
    Cell Commun Signal; 2021 Feb; 19(1):22. PubMed ID: 33618712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.
    Al Tanoury Z; Schaffner-Reckinger E; Halavatyi A; Hoffmann C; Moes M; Hadzic E; Catillon M; Yatskou M; Friederich E
    PLoS One; 2010 Feb; 5(2):e9210. PubMed ID: 20169155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells.
    Janji B; Giganti A; De Corte V; Catillon M; Bruyneel E; Lentz D; Plastino J; Gettemans J; Friederich E
    J Cell Sci; 2006 May; 119(Pt 9):1947-60. PubMed ID: 16636079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner.
    Janji B; Vallar L; Al Tanoury Z; Bernardin F; Vetter G; Schaffner-Reckinger E; Berchem G; Friederich E; Chouaib S
    J Cell Mol Med; 2010 Jun; 14(6A):1264-75. PubMed ID: 19799649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-plastin regulates polarization and migration in chemokine-stimulated human T lymphocytes.
    Freeley M; O'Dowd F; Paul T; Kashanin D; Davies A; Kelleher D; Long A
    J Immunol; 2012 Jun; 188(12):6357-70. PubMed ID: 22581862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
    Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
    Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Implications of RSK1-3 in Human Breast Cancer.
    Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation.
    Tang ZN; Zhang F; Tang P; Qi XW; Jiang J
    Oncol Rep; 2011 Nov; 26(5):1243-50. PubMed ID: 21725611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK1 regulation of actin assembly in osteoclasts involves serine 5 phosphorylation of L-plastin.
    Si M; Goodluck H; Zeng C; Pan S; Todd EM; Morley SC; Qin X; Mohan S; Xing W
    J Cell Biochem; 2018 Dec; 119(12):10351-10357. PubMed ID: 30136304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The actin-bundling protein L-plastin-A double-edged sword: Beneficial for the immune response, maleficent in cancer.
    Schaffner-Reckinger E; Machado RAC
    Int Rev Cell Mol Biol; 2020; 355():109-154. PubMed ID: 32859369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
    Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
    Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.
    Klemke M; Rafael MT; Wabnitz GH; Weschenfelder T; Konstandin MH; Garbi N; Autschbach F; Hartschuh W; Samstag Y
    Int J Cancer; 2007 Jun; 120(12):2590-9. PubMed ID: 17290393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.
    Guo K; Liu Y; Zhou H; Dai Z; Zhang J; Sun R; Chen J; Sun Q; Lu W; Kang X; Chen P
    Cancer Sci; 2008 Mar; 99(3):486-96. PubMed ID: 18167130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion.
    Krueger JS; Keshamouni VG; Atanaskova N; Reddy KB
    Oncogene; 2001 Jul; 20(31):4209-18. PubMed ID: 11464287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.
    Roux PP; Shahbazian D; Vu H; Holz MK; Cohen MS; Taunton J; Sonenberg N; Blenis J
    J Biol Chem; 2007 May; 282(19):14056-64. PubMed ID: 17360704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP/PKA and PKCδ signaling pathway.
    Dezong G; Zhongbing M; Qinye F; Zhigang Y
    J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.